Profile of bacterial isolates and antimicrobial susceptibility: Multicenter study using a one-day cut-off;Perfil de aislamientos bacterianos y sensibilidad antimicrobiana. Estudio multicéntrico mediante corte de un día

Revista Espanola de Quimioterapia

Volumn 13, Issue 4, 2000, Pages 384-393

  Alonso, R ^a   Fernandez Aranguiz A ^a   Colom, K ^a   Herreras, A ^a   Cisterna, R ^a  

^a HOSPITAL DE BASURTO   (Spain)

Author keywords

Clinical sample; Isolates; Susceptibility

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; OXACILLIN; PENICILLIN DERIVATIVE; TEICOPLANIN; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CLINICAL TRIAL; COAGULASE NEGATIVE STAPHYLOCOCCUS; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FEMALE; GRAM POSITIVE BACTERIUM; HUMAN; LOWER RESPIRATORY TRACT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONHUMAN; PSEUDOMONAS AERUGINOSA; SKIN; SOFT TISSUE; URINALYSIS;

BACTERIAL INFECTIONS; CROSS INFECTION; HUMANS; LUNG DISEASES; MICROBIAL SENSITIVITY TESTS; SKIN DISEASES, BACTERIAL; URINARY TRACT INFECTIONS;

EID: 0034491924     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Antimicrobial drug resistance
2. Surveillance of the current resistance of nosocomial pathogens to antimicrobials
3. An 8 year microbe base survey of the epidemiology, frequency and antimicrobial agent susceptibility of Pseudomonas aeruginosa hospital isolates in the United Kingdom
4. The new threats of grampositive pathogens: Reemergence of things of the past
5. Antimicrobial activity and spectrum investigation of eight broad spectrum betalactam drugs: A 1997 surveillance trial in 102 medical centers in the United States
6. Staphylococcus aureus and coagulase-negative staphylococci from blood stream infections: Frequency of occurrence, antimicrobial susceptibility, and molecular (mecA) characterization of oxacillin resistance in the SCOPE program
7. The clinical significance of positive blood culture in the 1990s: A prospective comprehensive evaluation of microbiology epidemiology and outcome of bacteriemia and fungemia in adults
8. Survey of blood stream infections attributable to gram-positive cocci: Frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY antimicrobial surveillance program
9. Survey of bloodstream infections due to gramnegative bacilli: Frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America for the SENTRY antimicrobial surveillance program, 1997
10. Urinary tract infection: An overview
11. Changing trend in frequency and antimicrobial resistance of urinary pathogens in outpatients clinics and a hospital in southern Israel, 1991-1995
12. Catheter-associated urinary tract infections
13. Characteristics of pathogens causing urinary tract infections in hospitals in North America: Results from the SENTRY antimicrobial surveillance program, 1997
14. Frequency of occurrence and antimicrobial susceptibility of bacterial pathogens associated with skin and soft tissue infections during 1997 from an international surveillance programme
15. Infecciones de la piel y tejidos blandos
16. A dutch approach to methicillin-resistant Staphylococcus aureus
17. The current state of susceptibility to glycopeptides in Staphylococcus aureus from an international surveillance program
18. Acinetobacter spp. as nosocomial pathogens: Microbiological clinical and epidemiological features
19. Pneumonia
20. Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: Analysis of results from the SENTRY antimicrobial surveillance program (1997)
21. Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: Antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997)
22. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program
23. The prevalence of fluoroquinolone resistance among clinically significant respiratory tract isolates of Streptococcus pneumoniae in the United States and Canada-1997. Results from the SENTRY antimicrobial surveillance program
24. Comparative activity of 27 antimicrobial compounds against 698 Streptococcus pneumoniae isolates originating from 20 European university hospitals